In vitro induction of specific anti-tumoral immunity against laryngeal carcinoma by using human interleukin-12 gene-transfected dendritic cells

Chinese Medical Journal

Volumn 124, Issue 9, 2011, Pages 1357-1361

  Liang, Wen ^a   Wang, Xue feng ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Adenovirus vector; Dendritic cells; Immunotherapy; Interleukin 12; Laryngeal carcinoma

Indexed keywords

CD83 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 12; TETRAZOLIUM;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL BASED GENE THERAPY; CELL ISOLATION; CELL LYSATE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DNA SEQUENCE; DRUG CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO GENE TRANSFER; LARYNX CARCINOMA; PHENOTYPIC VARIATION; T LYMPHOCYTE ACTIVATION; VIRUS RECOMBINANT;

ADENOVIRIDAE; CELL LINE, TUMOR; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-12; LARYNGEAL NEOPLASMS;

EID: 79955980246     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Gao C, Pan J, Lu W, Zhang M, Zhou L, Tian J. In vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells. Anticancer Drugs 2009; 20: 807-814.
2. Nestle FO, Aliagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, et al. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat Med 1998; 4: 328-332.
3. Chang AE, Redman BG, Whitfield JR, Nickoloff BJ, Braun TM, Lee PP, et al. A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer. Clin Cancer Res 2002; 8: 1021-1032.
4. Matsuda K, Tsunoda T, Tanaka H, Umano Y, Tanimura H, Nukaya I, et al. Enhancement of cytotoxic T-lymphocyte responses in patients with gastrointestinal malignancies following vaccination with CEA peptide-pulsed dendritic cells. Cancer Immunol Immunother 2004; 53: 609-616.
5. Nair SK, Morse M, Boczkowski D, Cumming RI, Vasovoic L, Gilboa E, et al. Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells. Ann Surg 2002; 235: 540-549.
6. Geiger JD, Hutchinson RJ, Hohenkirk LF, McKenna EA, Yanik GA, Levine JE, et al. Vaccination of pediatric solid tumor patients with tumorlysate-pulse ddendritic cells can expand specific T cell and mediate tumor regression. Cancer Res 2001; 61: 8513-8519.
7. Zeuthen LH, Christensen HR, Frokiaer H. Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gram negative bacteria. Clin Vaccine Immuno1 2006; 13: 365-375.
8. Kordi-Tamandani DM, Shekari M, Suri V. Interleukin-12 Gene polymorphism and cervical cancer risk. Am J Clin Oncol 2009; 32: 524-528.
9. Kikuchi T, Akasaki Y, Irie M, Homma S, Abe T, Ohno T. Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells. Cancer Immunol Immunother 2001; 50: 337-344.
10. Marten A, Renoth S, Heinicke T, Albers P, Pauli A, Mey U, et al. Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma. Hum Gene Ther 2003; 14: 483-494.
11. Trefzer U, Herberth G, Wohlan K, Milling A, Thiemann M, Sharav T, et al. Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results. Vaccine 2005; 23: 2367-2373.
12. Shimizu T, Berhanu A, Redkinger RE Jr, Watkins S, Lotze MT, Barksdale EM Jr. Interleukin-12 transduced dendritic cells induce regression of established murine neuroblastoma. J Pediatr Surg 2001; 36: 1285-1292.
13. Redlinger RE, Mailliard RB, Barksdale EM. Neuroblastoma and dendritic cell function. Semin Pediatr Surg 2003; 13: 61-71.
14. Traxlmayr MW, Wesch D, Dohnal AM, Funovics P, Fischer MB, Kabelitz D, et al. Immune suppression by γδT-cells as a potential regulatory mechanism after cancer vaccination with IL-12 secreting dendritic cells. J Immunother 2010; 33: 40-52.
15. Lee WT, Tamai H, Cohen P, Teker AM, Shu S. Immunotherapy of established murine squamous cell carcinoma using fused dendritic-tumor cell hybrids. Arch Otolaryngol Head Neck Surg 2008; 134: 608-613.